Last reviewed · How we verify
Placebo of ofloxacine
Placebo of ofloxacine is a Small molecule drug developed by Assistance Publique - Hôpitaux de Paris. It is currently in Phase 3 development for Bacterial conjunctivitis.
This drug is a placebo, meaning it has no active pharmacological effect.
This drug is a placebo, meaning it has no active pharmacological effect. Used for Bacterial conjunctivitis.
At a glance
| Generic name | Placebo of ofloxacine |
|---|---|
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
As a placebo, ofloxacine's mechanism of action is essentially inert, with no known biological activity. It is used as a control in clinical trials to compare the efficacy of active treatments.
Approved indications
- Bacterial conjunctivitis
Common side effects
- Headache
- Dizziness
- Nausea
Key clinical trials
- Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia (NA)
- Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase (PHASE4)
- Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis (PHASE3)
- Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia (PHASE4)
- Local Antibiotic Delivery for Community Acquired Pneumonia (PHASE2, PHASE3)
- Safety, Tolerability and Efficacy of MP-376 Given for 28 Days to Cystic Fibrosis (CF) Patients (PHASE2)
- A Phase 2 Study of MP-376 to Prevent Acute Exacerbations in Chronic Obstructive Pulmonary Disease (COPD) Patients (PHASE2)
- MP-376 (Aeroquin™, Levofloxacin for Inhalation) in Patients With Cystic Fibrosis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Placebo of ofloxacine CI brief — competitive landscape report
- Placebo of ofloxacine updates RSS · CI watch RSS
- Assistance Publique - Hôpitaux de Paris portfolio CI
Frequently asked questions about Placebo of ofloxacine
What is Placebo of ofloxacine?
How does Placebo of ofloxacine work?
What is Placebo of ofloxacine used for?
Who makes Placebo of ofloxacine?
What development phase is Placebo of ofloxacine in?
What are the side effects of Placebo of ofloxacine?
Related
- Manufacturer: Assistance Publique - Hôpitaux de Paris — full pipeline
- Indication: Drugs for Bacterial conjunctivitis
- Compare: Placebo of ofloxacine vs similar drugs
- Pricing: Placebo of ofloxacine cost, discount & access